'Exciting' mRNA jab for melanoma being tested in British patients

The video discusses a personalized cancer treatment approach using Moderna's algorithm to identify neoantigens unique to a patient's tumor. This method involves comparing tumor DNA with host DNA to create a custom mRNA product, enhancing immunotherapy. The treatment aims to prevent cancer recurrence with minimal side effects, offering a promising future in cancer care.

What is the significance of comparing a patient's tumour DNA with their own host DNA?

How do neo antigens contribute to the development of personalized cancer therapies?

What are the common side effects reported in the study related to the new treatment?

In what way does this treatment strategy differ from traditional cancer therapies?

Why is the new treatment described as more than just a vaccine?